Precision Medicine Programs Becoming a High Priority for Health Systems | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Precision Medicine Programs Becoming a High Priority for Health Systems

October 5, 2017
by Rajiv Leventhal
| Reprints

A recent survey of health system leaders has revealed that developing a precision medicine program within their organization has become an important priority.

The research, conducted by The Health Management Academy in Alexandria, Va., identified a rapid investment by leading healthcare systems in precision medicine programs, with significant expectations of the impact of real-world outcomes on physician decision making.

The survey included participation from 21 chief medical officers and oncology leaders from healthcare systems that operate or own 296 hospitals that average 2.9 million annual admissions. The respondents were specifically queried on their awareness, integration, and operationalization of precision medicine at their respective institutions.

Some of the survey’s most significant takeaways include:

  • The majority (60 percent) of health systems indicated that developing a precision medicine program was a high (25 percent) or essential (35 percent) priority for their organizations’ aims. Just 5 percent responded that it was a low priority, with 5 percent also responding that it was not needed.
  • While 43 percent of respondents reported that they are currently implementing a precision medicine program, 19 percent said that such a program had been implemented in their health system in the last year. A precision medicine program was at least a year old in 10 percent of responding health systems. Just 9 percent said they are not considering a precision medicine program.
  • The leaders expect real-world outcomes data to have a significant bearing on physician decisions for the most complex oncology cases. Along those lines, 60 percent of respondents indicated that their health system is involved in a cancer data-sharing collaboration.

Oncology is the most common area in which health systems have implemented precision medicine, with 83 percent of responding CMOs indicating their health system has developed, or expects to develop a precision medicine program in this area. Other areas of focus for precision medicine include cardiology (33 percent), neurology (33 percent), epidemiology (33 percent) and prenatal (33 percent).

Overall health systems are prepared to build a precision oncology program, with more than two-thirds (69 percent) of responding health systems reporting they are very (37 percent) or somewhat (32 percent) prepared to build a precision oncology program, including establishing molecular tumor boards, developing common protocols, and educating oncologists.

With a primary focus in the oncology space, 89 percent of respondents said that they expect precision oncology to improve patient outcomes, help enroll and retain patients in their program, and also assist clinical trial accrual.

What’s more, with respect to software use to implement a precision medicine program, while 70 percent believe they need to invest in such technology, only 30 percent indicated they had allocated a budget for such software. The decision on which vendors to choose was driven by: clinical trial matching; clinical decision support; molecular tumor board support; data sharing across networks; data warehousing and analytics.

The leaders who responded to the survey did express concern that their oncologists did not always order the most appropriate molecular diagnostic tests (73 percent) or may lack in ability to accurately interpret the molecular information from these tests to guide their choice of the targeted treatment for the patient (63 percent).

And, when queried on reimbursement policies, half the respondents indicated the need for automation of prior authorization to improve use of molecular diagnostics and targeted therapies.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More



ONC Roundup: Senior Leadership Changes Spark Questions

The Office of the National Coordinator for Health IT (ONC) has continued to experience changes within its upper leadership, leading some folks to again ponder what the health IT agency’s role will be moving forward.

Media Report: Walmart Hires Former Humana Executive to Run Health Unit

Reigniting speculation that Walmart and insurer Humana are exploring ways to forge a closer partnership, Walmart Inc. has hired a Humana veteran to run its health care business, according to a report from Bloomberg.

Value-Based Care Shift Has Halted, Study Finds

A new study of 451 physicians and health plan executives suggests that progress toward value-based care has stalled. In fact, it may have even taken a step backward over the past year, the research revealed.

Study: EHRs Tied with Lower Hospital Mortality, But Only After Systems Have Matured

Over the past decade, there has been significant national investment in electronic health record (EHR) systems at U.S. hospitals, which was expected to result in improved quality and efficiency of care. However, evidence linking EHR adoption to better care is mixed, according to medical researchers.

Nursing Notes Can Help Predict ICU Survival, Study Finds

Researchers at the University of Waterloo in Ontario have found that sentiments in healthcare providers’ nursing notes can be good indicators of whether intensive care unit (ICU) patients will survive.

Health Catalyst Completes Acquisition of HIE Technology Company Medicity

Salt Lake City-based Health Catalyst, a data analytics company, has completed its acquisition of Medicity, a developer of health information exchange (HIE) technology, and the deal adds data exchange capabilities to Health Catalyst’s data, analytics and decision support solutions.